- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05264701
Investigation of the Effects of the Technology-based Cardiac Rehabilitation Program in Coronary Artery Patients
June 17, 2024 updated by: Dilara Saklica, Hacettepe University
Investigation of the Effects of Artificial Intelligence-supported and Technology-based Cardiac Rehabilitation Programs on Participation and Exercise Capacity in Coronary Artery Patients
This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.
Study Overview
Status
Completed
Conditions
Detailed Description
Cardiovascular diseases constitute one of the most critical health problems of today's society due to the loss of workforce, morbidity, mortality, and high hospital expenses.
This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06100
- Hacettepe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with coronary artery disease
- Access to the online program
- Volunteering to participate in the research
- Having an iOS or Android operating system compatible phone
Exclusion Criteria:
- Having a musculoskeletal problem
- Having uncontrolled hypertension
- Having chronic heart failure (NYHA III-IV)
- A history of acute coronary syndrome or surgical revascularization less than 12 months ago
- More than 50% occlusion on the main coronary artery
- Having arrhythmia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physiotherapist Supervised Exercise Training Group
Physiotherapist supervised exercise training in patients with coronary artery disease
|
Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.
|
|
Experimental: Exercise Training Tracking from Phone-app Group
Exercise training tracking from phone app in patients with coronary artery disease
|
Exercise training for 12 weeks will be given over the developed phone application.
|
|
Experimental: Control Group
General physical activity recommendations for home
|
The program will be consist of 12 weeks of physical activity recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise Capacity
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Exercise capacity will be evaluated using the incremental shuttle walk test.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Participation
Time Frame: after 12 weeks
|
Participation will be evaluated using the number of sessions attended.
|
after 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peripheral muscle strength
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Peripheral muscle strength will be evaluated using the dynamometer.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Endothelial function
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
The endothelial function will be evaluated using echocardiography.
After a resting baseline, Brachial artery diameter will be recorded, the cuff used in blood pressure measurement will be inflated 25-50 mmHg above the systolic blood pressure value and maintain that pressure for 5 min.
The brachial artery diameter will be measured again after the cuff is deflated.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Healthy Living Habit Evaluation
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Healthy living habit evaluation will be evaluated using the Healthy Lifestyle Behaviors Scale-II.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Health-Related Quality of Life
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Health-Related Quality of Life will be evaluated using the Myocardial Infarction Dimensional Assessment Scale (MIDAS).
|
Baseline, after 12 weeks, after 24 weeks
|
|
QoL
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Quality of life will be evaluated using the SF-36 Short Form.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Maximal Effort Capacity
Time Frame: Baseline
|
Maximal effort capacity will be evaluated using a cardiovascular stress test.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Naciye Vardar-Yagli, PhD, Hacettepe University
- Study Director: Hikmet Yorgun, PhD, Hacettepe University
- Study Chair: Ahmet Hakan Ates, PhD, Hacettepe University
- Study Chair: Deniz Yuce, PhD, Hacettepe University
- Principal Investigator: Dilara Saklica, MSc, Hacettepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 7, 2022
Primary Completion (Actual)
May 1, 2024
Study Completion (Actual)
May 1, 2024
Study Registration Dates
First Submitted
February 19, 2022
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 3, 2022
Study Record Updates
Last Update Posted (Actual)
June 18, 2024
Last Update Submitted That Met QC Criteria
June 17, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA-20105
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Physiotherapist supervised exercise training
-
University of AarhusOslo University Hospital; Tampere University Hospital; Regionshospitalet Viborg...CompletedProximal Humeral FractureNorway, Denmark
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Istanbul Medeniyet UniversityNot yet recruiting
-
The University of Hong KongNot yet recruitingPain | Knee OsteoarthritisHong Kong
-
Hvidovre University HospitalActive, not recruitingShoulder Instability Subluxation BilateralDenmark
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
University of SevilleUniversity Hospital Virgen del Rocio, SevillaNot yet recruitingPhysical Activity | Exercise | Abdominal Wall Hernia | Prevention
-
Medical University of ViennaUnknownPeripheral Artery DiseaseAustria
-
Chang Gung Memorial HospitalCompleted
-
Paracelsus Medical UniversityLudwig Boltzmann Institute for Digital Health and PreventionCompleted